JP2002516284A5 - - Google Patents

Download PDF

Info

Publication number
JP2002516284A5
JP2002516284A5 JP2000550491A JP2000550491A JP2002516284A5 JP 2002516284 A5 JP2002516284 A5 JP 2002516284A5 JP 2000550491 A JP2000550491 A JP 2000550491A JP 2000550491 A JP2000550491 A JP 2000550491A JP 2002516284 A5 JP2002516284 A5 JP 2002516284A5
Authority
JP
Japan
Prior art keywords
composition
toxin
oligosaccharide
oligosaccharide sequence
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000550491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002516284A (ja
Filing date
Publication date
Priority claimed from US09/085,032 external-priority patent/US6013635A/en
Application filed filed Critical
Publication of JP2002516284A publication Critical patent/JP2002516284A/ja
Publication of JP2002516284A5 publication Critical patent/JP2002516284A5/ja
Pending legal-status Critical Current

Links

JP2000550491A 1998-05-28 1999-05-27 Ｃ．ｄｉｆｆｉｃｉｌｅトキシンＢ関連性状態の処置 Pending JP2002516284A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/085,032 1998-05-28
US09/085,032 US6013635A (en) 1998-05-28 1998-05-28 Treatment of C. difficile toxin B associated conditions
PCT/CA1999/000484 WO1999061031A1 (en) 1998-05-28 1999-05-27 Treatment of c. difficile toxin b associated conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006136969A Division JP2006213735A (ja) 1998-05-28 2006-05-16 Ｃ．ｄｉｆｆｉｃｉｌｅトキシンＢ関連性状態の処置

Publications (2)

Publication Number Publication Date
JP2002516284A JP2002516284A (ja) 2002-06-04
JP2002516284A5 true JP2002516284A5 (enExample) 2006-07-06

Family

ID=22189033

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000550491A Pending JP2002516284A (ja) 1998-05-28 1999-05-27 Ｃ．ｄｉｆｆｉｃｉｌｅトキシンＢ関連性状態の処置
JP2006136969A Pending JP2006213735A (ja) 1998-05-28 2006-05-16 Ｃ．ｄｉｆｆｉｃｉｌｅトキシンＢ関連性状態の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006136969A Pending JP2006213735A (ja) 1998-05-28 2006-05-16 Ｃ．ｄｉｆｆｉｃｉｌｅトキシンＢ関連性状態の処置

Country Status (10)

Country Link
US (3) US6013635A (enExample)
EP (2) EP1089740B8 (enExample)
JP (2) JP2002516284A (enExample)
CN (1) CN1298306A (enExample)
AT (1) ATE387205T1 (enExample)
AU (1) AU4125399A (enExample)
CA (1) CA2321927A1 (enExample)
DE (2) DE69938241T2 (enExample)
NO (1) NO20005992L (enExample)
WO (1) WO1999061031A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034129A (en) * 1996-06-24 2000-03-07 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US6290947B1 (en) 1997-09-19 2001-09-18 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin-binding agents
US6013635A (en) * 1998-05-28 2000-01-11 Synsorb Biotech, Inc. Treatment of C. difficile toxin B associated conditions
US6358930B1 (en) * 1998-05-28 2002-03-19 Synsorb Biotech Inc. Treatment of C. difficile toxin B associated conditions
US6482402B1 (en) 1999-05-13 2002-11-19 Geltex Pharmaceuticals, Inc. Antimicrobial compositions and methods
US6867194B2 (en) 2001-08-09 2005-03-15 Wayne State University Enzyme activated nitric oxide donors
US20050287552A1 (en) * 2003-02-19 2005-12-29 Academia Sinica, Office Of Public Affairs (Technology Transfer) Carbohydrate encapsulated nanoparticle based affinity mass spectrometry
US7695738B2 (en) * 2003-02-19 2010-04-13 Academia Sinica Carbohydrate encapsulated nanoparticles
BRPI0409420A (pt) * 2003-04-18 2006-04-25 Merck Patent Gmbh pigmentos antimicrobianos
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US7682631B2 (en) 2003-10-01 2010-03-23 Clemson University Adhesin-specific nanoparticles and process for using same
WO2005041657A1 (en) * 2003-10-20 2005-05-12 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
EP1802349A1 (en) * 2004-10-13 2007-07-04 Ilypsa, Inc. Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle
US20060078534A1 (en) * 2004-10-13 2006-04-13 Dominique Charmot Toxin binding compositions
EP2054044B1 (de) * 2006-08-02 2014-07-23 Johannes Gutenberg-Universität Mainz Arzneimittel gegen lct-vergiftungen
CN101855336B (zh) * 2007-09-14 2019-07-30 赛诺菲巴斯德生物制剂有限责任公司 含艰难梭菌类毒素a和b的药物组合物
FR2964116B1 (fr) * 2010-09-01 2017-06-02 Biomerieux Sa Utilisation d'un activateur de beta-glucosidase pour la detection et/ou l'identification de c.difficile
CN102181457B (zh) * 2011-03-21 2012-07-04 王世霞 密码子优化的艰难梭菌外毒素b氨基端基因序列及其核酸疫苗
GB2491117A (en) * 2011-05-20 2012-11-28 Royal Holloway & Bedford New College Coat proteins from Clostridium and Bacillus species
CN104785019B (zh) * 2015-04-09 2017-01-11 东华大学 异形熔喷纤维制备的高效低阻空气过滤材料

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
DE69232928D1 (de) * 1991-08-23 2003-03-27 Alberta Res Council Verfahren und zusammensetzungen zur verhinderung der antikörper-vermittelten abstossung von xenogenen transplantaten
US5484773A (en) * 1994-02-14 1996-01-16 Alberta Research Council Treatment of antibiotic associated diarrhea
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US5811409A (en) * 1995-06-05 1998-09-22 Synsorb Biotech, Inc. Treatment of cholera
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5846943A (en) * 1996-11-08 1998-12-08 Synsorb Biotech, Inc. Solid support matricles containing a toxin binding oligosaccharide
ZA983690B (en) * 1998-04-02 1999-02-04 Synsorb Biotech Inc Solid support matrices containing a toxin binding oligosaccharide
US6013635A (en) * 1998-05-28 2000-01-11 Synsorb Biotech, Inc. Treatment of C. difficile toxin B associated conditions

Similar Documents

Publication Publication Date Title
JP2002516284A5 (enExample)
JP4137184B2 (ja) 薬物複合体の製造方法
JP2002527052A5 (enExample)
AU2003219922B2 (en) Compositions for delivery of therapeutics and other materials, and methods of making and using the same
TW496870B (en) Compositions methods for stimulating megakaryocyte growth and differentiation
JPH11509223A5 (enExample)
JP2002541233A5 (enExample)
IL135148A0 (en) A polysaccharide conjugate and pharmaceutical compositions containing the same
HK1042046A1 (zh) 帶可水解親脂組分的兩性藥/低聚物的共軛物及其生產和使用方法
CA2312004A1 (en) Site-specific preparation of polyethylene glycol-grf conjugates
WO2007000342A3 (en) Immunogenic composition
JP2003113113A5 (enExample)
JP2002511424A5 (enExample)
EP1185305A4 (en) OLIGOMERIC COMPOUNDS CONJUGATED TO A LIGAND
JPH06502391A (ja) ポリマー性薬剤送達システム
JP2001200034A5 (enExample)
JP2001509167A (ja) Ｈ．ｐｙｌｏｒｉ感染を処置するための方法および結合体
JP2002544214A5 (enExample)
JP2004512258A5 (enExample)
WO2001010951A8 (fr) Compositions de polymeres styreniques antistatiques
JP2002522501A5 (enExample)
JP2002520288A5 (enExample)
JP2003513051A5 (enExample)
WO1999014345A3 (de) Arzneimittel zur therapie einer manifesten lyme-borreliose
DE60025426D1 (de) Alkylmethyl/Alkylarylsiloxanterpolymere mit hohem Molekulargewicht und niedrigem SiH-Gehalt und Verfahren zu ihrer Herstellung